CCS
CL icon

Concentric Capital Strategies’s Colgate-Palmolive CL Stock Holding History

Concentric Capital Strategies’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,191
Closed -$3.08M – 334
2026
Q1 		$3.08M Buy
+36,191
New +$3.23M 0.26% 68

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Concentric Capital Strategies's CL Position: Q2 2026 in Review

Concentric Capital Strategies sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 36,191 shares — an estimated $3.08M sold.

Concentric Capital Strategies first reported a position in CL in Q1 2026 and held it in 1 quarter. The position peaked at $3.08M in Q1 2026. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Concentric Capital Strategies reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Concentric Capital Strategies sold 36,191 Colgate-Palmolive shares in Q2 2026, an estimated $3.08M.
  • Concentric Capital Strategies first reported a position in Colgate-Palmolive in Q1 2026 and held it in 1 quarter.
  • Concentric Capital Strategies's Colgate-Palmolive position peaked at $3.08M in Q1 2026.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.